The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodriguez, M.
Right arrow Articles by Jaenisch, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez, M.
Right arrow Articles by Jaenisch, R.

The Journal of Immunology, Vol 151, Issue 1 266-276, Copyright © 1993 by American Association of Immunologists


ARTICLES

Abrogation of resistance to Theiler's virus-induced demyelination in H- 2b mice deficient in beta 2-microglobulin

M Rodriguez, AJ Dunkel, RL Thiemann, J Leibowitz, M Zijlstra and R Jaenisch
Department of Neurology, Mayo Clinic, Rochester, MN 55901.

Intracerebral infection of susceptible strains of mice with Theiler's virus, a picornavirus, results in central nervous system demyelination, which is similar to multiple sclerosis. Immunogenetic experiments indicate that the MHC (H-2) and, in particular, the D region that controls class I-restricted immune responses, is an important determinant to development of demyelination. We tested whether disruption of beta 2-microglobulin (beta 2-m) would abrogate resistance to demyelinating disease normally observed in H-2b mice. All (C57BI/6 x 129)F3 mice transgenic for homozygous beta 2-m gene disruption (-/-) developed chronic demyelination after Theiler's murine encephalomyelitis virus infection, whereas none of the infected littermates with normal expression of class I MHC (beta 2-m, +/+) developed demyelination. Demyelinated lesions showed class II MHC expression, macrophages, and TNF but no class I MHC expression or CD8+ T cells. No correlation was observed between development of demyelination and delayed-type hypersensitivity responses to virus Ag. Despite the presence of demyelinating lesions, none of the infected beta 2-m (-/-) mice developed neurologic deficits. Infectious virus and virus Ag persisted in the central nervous systems of infected beta 2-m (-/-) mice but not in beta 2-m (+/+) mice. These experiments support the hypothesis that a class I immune response mediated by CD8+ T cells is important in resistance to Theiler's murine encephalomyelitis virus- induced demyelination. Development of chronic neurologic deficits as observed in immunocompetent susceptible strains of mice may be dependent on the presence of class I MHC and CD8+ T cells.


This article has been cited by other articles:


Home page
J. Virol.Home page
J. Myoung, Y. Y. Bahk, H. S. Kang, M. C. Dal Canto, and B. S. Kim
Anticapsid Immunity Level, Not Viral Persistence Level, Correlates with the Progression of Theiler's Virus-Induced Demyelinating Disease in Viral P1-Transgenic Mice
J. Virol., June 1, 2008; 82(11): 5606 - 5617.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Rodriguez, L. Zoecklein, J. G. Kerkvliet, K. D. Pavelko, L. Papke, C. L. Howe, L. R. Pease, and C. David
Human HLA-DR Transgenes Protect Mice from Fatal Virus-Induced Encephalomyelitis and Chronic Demyelination
J. Virol., April 1, 2008; 82(7): 3369 - 3380.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. T. Getts, B. S. Kim, and S. D. Miller
Differential Outcome of Tolerance Induction in Naive versus Activated Theiler's Virus Epitope-Specific CD8+ Cytotoxic T Cells
J. Virol., June 15, 2007; 81(12): 6584 - 6593.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
X. Lin, X. Ma, M. Rodriguez, and R. P. Roos
CD4+ T cells are important for clearance of DA strain of TMEV from the central nervous system of SJL/J mice
Int. Immunol., September 1, 2004; 16(9): 1237 - 1240.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas
Theiler's Virus Infection: a Model for Multiple Sclerosis
Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Rodriguez, L. J. Zoecklein, C. L. Howe, K. D. Pavelko, J. D. Gamez, S. Nakane, and L. M. Papke
Gamma Interferon Is Critical for Neuronal Viral Clearance and Protection in a Susceptible Mouse Strain following Early Intracranial Theiler's Murine Encephalomyelitis Virus Infection
J. Virol., November 15, 2003; 77(22): 12252 - 12265.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. D. Pavelko, C. L. Howe, K. M. Drescher, J. D. Gamez, A. J. Johnson, T. Wei, R. M. Ransohoff, and M. Rodriguez
Interleukin-6 Protects Anterior Horn Neurons from Lethal Virus-Induced Injury
J. Neurosci., January 15, 2003; 23(2): 481 - 492.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B.-S. Kang, M. A. Lyman, and B. S. Kim
Differences in Avidity and Epitope Recognition of CD8+ T Cells Infiltrating the Central Nervous Systems of SJL/J Mice Infected with BeAn and DA Strains of Theiler's Murine Encephalomyelitis Virus
J. Virol., November 20, 2002; 76(22): 11780 - 11784.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
X. Lin, M. K. Njenga, A. J. Johnson, K. D. Pavelko, C. S. David, L. R. Pease, and M. Rodriguez
Transgenic Expression of Theiler's Murine Encephalomyelitis Virus Genes in H-2b Mice Inhibits Resistance to Virus-Induced Demyelination
J. Virol., June 27, 2002; 76(15): 7799 - 7811.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B.-S. Kang, M. A. Lyman, and B. S. Kim
The Majority of Infiltrating CD8+ T Cells in the Central Nervous System of Susceptible SJL/J Mice Infected with Theiler's Virus Are Virus Specific and Fully Functional
J. Virol., June 5, 2002; 76(13): 6577 - 6585.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. A. Lyman, H.-G. Lee, B. S. Kang, H.-K. Kang, and B. S. Kim
Capsid-Specific Cytotoxic T Lymphocytes Recognize Three Distinct H-2Db-Restricted Regions of the BeAn Strain of Theiler's Virus and Exhibit Different Cytokine Profiles
J. Virol., March 7, 2002; 76(7): 3125 - 3134.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
K. M. Drescher, S. L. Johnston, W. Hogancamp, G. H. Nabozny, C. S. David, I. J. Rimm, P. J. Wettstein, and M. Rodriguez
V{beta}8+ T cells protect from demyelinating disease in a viral model of multiple sclerosis
Int. Immunol., March 1, 2000; 12(3): 271 - 280.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. J. Johnson, M. K. Njenga, M. J. Hansen, S. T. Kuhns, L. Chen, M. Rodriguez, and L. R. Pease
Prevalent Class I-Restricted T-Cell Response to the Theiler's Virus Epitope Db:VP2121-130 in the Absence of Endogenous CD4 Help, Tumor Necrosis Factor Alpha, Gamma Interferon, Perforin, or Costimulation through CD28
J. Virol., May 1, 1999; 73(5): 3702 - 3708.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
X. Lin, R. P. Roos, L. R. Pease, P. Wettstein, and M. Rodriguez
A Theiler's Virus Alternatively Initiated Protein Inhibits the Generation of H-2K-Restricted Virus-Specific Cytotoxicity
J. Immunol., January 1, 1999; 162(1): 17 - 24.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Z. C. Neal and G. A. Splitter
Protection against Lethal Encephalomyocarditis Virus Infection in the Absence of Serum-Neutralizing Antibodies
J. Virol., October 1, 1998; 72(10): 8052 - 8060.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. D. Murray, K. D. Pavelko, J. Leibowitz, X. Lin, and M. Rodriguez
CD4+ and CD8+ T Cells Make Discrete Contributions to Demyelination and Neurologic Disease in a Viral Model of Multiple Sclerosis
J. Virol., September 1, 1998; 72(9): 7320 - 7329.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Lin, L. R. Pease, P. D. Murray, and M. Rodriguez
Theiler's Virus Infection of Genetically Susceptible Mice Induces Central Nervous System-Infiltrating CTLs with no Apparent Viral or Major Myelin Antigenic Specificity
J. Immunol., June 1, 1998; 160(11): 5661 - 5668.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.